← All patents

US20180117101A1

Genetically modified probiotic for the treatment of phenylketonuria (pku) …

University of North Texas

Abstract

A GMP adapted to provide the PAL gene for the treatment of PKU when administered orally. The GMP of the present invention may include a probiotic, a PAL gene to be expressed using the probiotic, wherein the PAL gene is functionally attached to a promoter and a ribosome binding site, and may be …

University
University of North Texas
Assignee
University Of North Texas
Inventor
Katherine Durrer
Priority date
July 27, 2012
Filing date
November 01, 2017
Publication date
May 03, 2018
Language
en
Metadata fetched
August 28, 2026 19:12